Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REACTIC-TAVI Trial: Platelet REACtivity According to TICagrelor Dose After Transcatheter AorticValve Implantation. A Pilot Study.

NCT04331145 is registered in ClinicalTrials.gov with Andres Iñiguez Romo as lead sponsor.

NCT NCT04331145
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04331145 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REACTIC-TAVI Trial: Platelet REACtivity According to TICagrelor Dose After Transcatheter AorticValve Implantation. A Pilot Study.
Lead sponsor
Andres Iñiguez Romo
Phase
Phase 4
Overall status
Completed
Start date
June 23, 2020
Completion date
February 28, 2022
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

symptomatic aortic stenosis